Back

Incidence of malignant ventricular arrhythmia and identifying risk factors in patients with advanced heart failuure on continuous at home inotropic therapy

20 March 2018 (09:20 - 09:30)
Organised by:
Congress Presentation Part of: Novel aspect in ventricular arrhythmia management Ventricular Arrhythmias and SCD - Clinical EHRA Premium Access EHRA 2018

About the speaker

Photo
Mr Christopher Grubb

New York (United States of America)

8 More presentations in this session

Presentation thumbnail
Transmural activation delay to predict the architecture of fibrosis using whole heart histology in patients with non-ischemic cardiomyopathy and ventricular tachycardia
Ms C. Glashan (Leiden, NL)
Abstract
Presentation thumbnail
Quantitative assessment of myocardial scar heterogeneity using texture analysis to predict implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging
Doctor J. Gould (London, GB)
Abstract
Presentation thumbnail
First line epicardial approach in the setting of complex arrhythmia substrates
Doctor C. Bisceglia (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Phrenic nerve limitation during epicardial catheter ablation for ventricular tachycardia
Doctor K. Okubo (Yokosuka, JP)
Abstract
Presentation thumbnail
Embolic debris captured by a cerebral protection system during catheter ablation of ventricular tachycardia in patients with ischemic heart disease
Doctor C. Heeger (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Novel aspect in ventricular arrhythmia management

The Event

Event poster

EHRA 2018

20 March 2018 09:20 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources